Matrix Metalloproteinases as Drug Targets in Infections Caused by Gram-Negative Bacteria and in Septic Shock

SUMMARY The mammalian immune system is optimized to cope effectively with the constant threat of pathogens. However, when the immune system overreacts, sepsis, severe sepsis, or septic shock can develop. Despite extensive research, these conditions remain the leading cause of death in intensive care units. The matrix metalloproteinases (MMPs) constitute a family of proteases that are expressed in developmental, physiological, and pathological processes and also in response to infections. Studies using MMP inhibitors and MMP knockout mice indicate that MMPs play essential roles in infection and in the host defense against infection. This review provides a brief introduction to some basic concepts of infections caused by gram-negative bacteria and reviews reports describing MMP expression and inhibition, as well as studies with MMP-deficient mice in models of infection caused by gram-negative bacteria and of septic shock. We discuss whether MMPs should be considered novel drug targets in infection and septic shock.

[1]  K. Bodger,et al.  Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine Helicobacter infection , 2007, Journal of Clinical Pathology.

[2]  G. Opdenakker,et al.  Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis. , 2008, FEMS immunology and medical microbiology.

[3]  J. Klossek,et al.  Pseudomonas Aeruginosa Virulence Factors Delay Airway Epithelial Wound Repair by Altering the Actin Cytoskeleton and Inducing Overactivation of Epithelial Matrix Metalloproteinase–2 , 2000, Laboratory Investigation.

[4]  J. Platt,et al.  Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 41 , 2004, The Journal of Immunology.

[5]  P. E. Van den Steen,et al.  Inhibition of lethal endotoxin shock with an L-pyridylalanine containing metalloproteinase inhibitor selected by high-throughput screening of a new peptide library. , 2006, Combinatorial chemistry & high throughput screening.

[6]  Tao Xu,et al.  The role of neutrophil collagenase in endotoxic acute lung injury. , 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[7]  B. Haynes,et al.  Resistance of CD7-deficient Mice to Lipopolysaccharide-induced Shock Syndromes , 1999, The Journal of experimental medicine.

[8]  R. Dellinger,et al.  Treatment options for severe sepsis and septic shock , 2006, Expert review of anti-infective therapy.

[9]  P. E. Van den Steen,et al.  Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. , 2005, Biochemical pharmacology.

[10]  L. Brown,et al.  Ethanol ingestion increases activation of matrix metalloproteinases in rat lungs during acute endotoxemia. , 1999, American journal of respiratory and critical care medicine.

[11]  C. Janeway,et al.  Introduction: the role of innate immunity in the adaptive immune response , 1998, Seminars in immunology.

[12]  L. Rather,et al.  Disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by Galen to the four cardinal signs of Celsus. , 1971, Bulletin of the New York Academy of Medicine.

[13]  M. Imtiaz,et al.  A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice. , 2007, Microbes and infection.

[14]  Jonathan Cohen The immunopathogenesis of sepsis , 2002, Nature.

[15]  G. Dougan,et al.  Impaired Immunity to Intestinal Bacterial Infection in Stromelysin-1 (Matrix Metalloproteinase-3)-Deficient Mice1 , 2004, The Journal of Immunology.

[16]  Marian F Young,et al.  The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. , 2005, The Journal of clinical investigation.

[17]  M. Lalu,et al.  Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: A potential role for MMP-9 , 2003, Molecular and Cellular Biochemistry.

[18]  Jerome F. Strauss,et al.  The Extra Domain A of Fibronectin Activates Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[19]  M. Sitkovsky,et al.  Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.

[20]  C. Brinckerhoff,et al.  Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. , 1992, Journal of cellular biochemistry.

[21]  M. Lalu,et al.  Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia , 2004, Critical care medicine.

[22]  J. Dhainaut,et al.  LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. , 1999, American journal of respiratory and critical care medicine.

[23]  C. Overall,et al.  Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. , 2008, Blood.

[24]  Ivan Stamenkovic,et al.  Extracellular matrix remodelling: the role of matrix metalloproteinases , 2003, The Journal of pathology.

[25]  X. Puente,et al.  Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. , 1996, Cancer research.

[26]  S. Landas,et al.  CHEMICALLY MODIFIED TETRACYCLINE (COL-3) IMPROVES SURVIVAL IF GIVEN 12 BUT NOT 24 HOURS AFTER CECAL LIGATION AND PUNCTURE , 2006, Shock.

[27]  Keiko Ozato,et al.  Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. , 2002, BioTechniques.

[28]  M. Borggrefe,et al.  Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: Prognostic value of TIMP-1 in severe sepsis , 2006, Scandinavian journal of infectious diseases.

[29]  R. Gibson,et al.  Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[30]  J. Varani,et al.  Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases. , 1999, American journal of respiratory cell and molecular biology.

[31]  Kyung-Chan Kim,et al.  MAP Kinase activation is required for the MMP-9 induction by TNF-stimulation , 2005, Archives of pharmacal research.

[32]  P. Libby,et al.  Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. , 1998, Journal of immunology.

[33]  B. Fingleton,et al.  Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.

[34]  L. Matrisian,et al.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. , 1999, Science.

[35]  Kirby I Bland,et al.  CECAL LIGATION AND PUNCTURE , 2005, Shock.

[36]  T. Standiford,et al.  Anti-Tumor Necrosis Factor-&agr; Therapy During Murine Klebsiella pneumoniae Bacteremia: Increased Mortality in the Absence of Liver Injury , 2003, Shock.

[37]  N. Webster,et al.  Matrix metalloproteinase‐9 concentrations in critically ill patients , 2001, Anaesthesia.

[38]  S. Mita,et al.  Differential effects between marimastat, a TNF-α converting enzyme inhibitor, and anti-TNF-α antibody on murine models for sepsis and arthritis , 2002 .

[39]  E. Cillari,et al.  Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood , 1997, Antimicrobial agents and chemotherapy.

[40]  M. Sung,et al.  Matrix metalloproteinase‐2 (MMP‐2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP‐ribose) polymerase (PARP) in vitro , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  J. Cohen Mechanisms of Tissue Injury in Sepsis: Contrasts between Gram Positive and Gram Negative Infection , 2001, Journal of chemotherapy.

[42]  T. Mak,et al.  Cutting Edge: Tissue Inhibitor of Metalloproteinase 3 Regulates TNF-Dependent Systemic Inflammation , 2006, The Journal of Immunology.

[43]  Jonathan Cohen,et al.  The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit , 2005, Critical care medicine.

[44]  M. Rojas,et al.  Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. , 2005, Gastroenterology.

[45]  P. Berna,et al.  Effects of depletion of neutrophils or macrophages on the inflammatory response induced by metalloelastase (MMP-12) in mice airways. , 2008, European journal of pharmacology.

[46]  C. Brinckerhoff,et al.  Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. , 1996, Gene expression.

[47]  M. Menger,et al.  Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of D‐galactosamine‐sensitized mice to lipopolysaccharide , 2007, British journal of pharmacology.

[48]  B. Haye,et al.  TIMPs as multifacial proteins. , 2004, Critical reviews in oncology/hematology.

[49]  S. Mita,et al.  Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis. , 2002, Cytokine.

[50]  R. Veldhuizen,et al.  Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation, and hyperoxia. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[51]  R. Veldhuizen,et al.  Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[52]  L. Hazlett,et al.  Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection. , 2006, Investigative ophthalmology & visual science.

[53]  D. Remick,et al.  Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. , 2000, Shock.

[54]  M. Imtiaz,et al.  Inhibition of Matrix Metalloproteinases Protects Mice from Ascending Infection and Chronic Disease Manifestations Resulting from Urogenital Chlamydia muridarum Infection , 2006, Infection and Immunity.

[55]  G. Rosenberg,et al.  Stromelysin-1 and gelatinase A are upregulated before TNF-α in LPS-stimulated neuroinflammation , 2002, Brain Research.

[56]  G. Rosenberg,et al.  Blood–brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation , 2006, Neurobiology of Disease.

[57]  B. Beutler,et al.  Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. , 2008, Immunobiology.

[58]  David B. Alexander,et al.  The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis , 2001, Cell.

[59]  Marie M. Lee,et al.  Tissue Inhibitor of Metalloproteinase 1 Regulates Resistance to Infection , 2005, Infection and Immunity.

[60]  C. Elson,et al.  A Novel Role for Defensins in Intestinal Homeostasis: Regulation of IL-1β Secretion1 , 2007, The Journal of Immunology.

[61]  B. Mecham,et al.  Individual Matrix Metalloproteinases Control Distinct Transcriptional Responses in Airway Epithelial Cells Infected with Pseudomonas aeruginosa , 2007, Infection and Immunity.

[62]  N. Oku,et al.  Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP. , 2003, Biological & pharmaceutical bulletin.

[63]  C. Liang,et al.  Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. , 1999, American journal of respiratory cell and molecular biology.

[64]  J. Vincent Drotrecogin alfa (activated): the treatment for severe sepsis? , 2007, Current drug safety.

[65]  S. Wessler,et al.  p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7. , 2008, Molecular biology of the cell.

[66]  P. Libby,et al.  Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. , 1998, Circulation.

[67]  E. Peterson,et al.  Role of matrix metalloproteinase‐7 in the modulation of a Chlamydia trachomatis infection , 2006, Immunology.

[68]  W. Parks,et al.  Epilysin, a Novel Human Matrix Metalloproteinase (MMP-28) Expressed in Testis and Keratinocytes and in Response to Injury* , 2001, The Journal of Biological Chemistry.

[69]  P. Berna,et al.  Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat. , 2007, European journal of pharmacology.

[70]  U. Shankavaram,et al.  Differential Regulation of Lipopolysaccharide-Induced Monocyte Matrix Metalloproteinase (MMP)-1 and MMP-9 by p38 and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinases , 2003, The Journal of Immunology.

[71]  S. Handley,et al.  General and specific host responses to bacterial infection in Peyer's patches: a role for stromelysin‐1 (matrix metalloproteinase‐3) during Salmonella enterica infection , 2007, Molecular microbiology.

[72]  T. Sato,et al.  Activation of human progelatinase A/promatrix metalloproteinase 2 by Escherichia coli-derived serine proteinase. , 2000, Biochemical and biophysical research communications.

[73]  D. Gingras,et al.  Matrix metalloproteinase inhibition by green tea catechins. , 2000, Biochimica et biophysica acta.

[74]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[75]  A. Noël,et al.  Resistance of Collagenase-2 (Matrix Metalloproteinase-8)-Deficient Mice to TNF-Induced Lethal Hepatitis1 , 2005, The Journal of Immunology.

[76]  Schroen Dj,et al.  Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. , 1996 .

[77]  J. Friedland,et al.  The paradox of matrix metalloproteinases in infectious disease , 2005, Clinical and experimental immunology.

[78]  C. Sprung,et al.  Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.

[79]  P. Soloway,et al.  Hyper‐resistance to Infection in TIMP‐1‐Deficient Mice Is Neutrophil Dependent but Not Immune Cell Autonomous , 1999, Annals of the New York Academy of Sciences.

[80]  L. Moldawer,et al.  A MATRIX METALLOPROTEINASE INHIBITOR PREVENTS PROCESSING OF TUMOR NECROSIS FACTOR α (TNFα) AND ABROGATES ENDOTOXIN‐INDUCED LETHALITY , 1997 .

[81]  A. H. Drummond,et al.  Processing of tumour necrosis factor-alpha precursor by metalloproteinases. , 1994, Nature.

[82]  W. Parks,et al.  Control of matrix metalloproteinase catalytic activity. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[83]  L. Joosten,et al.  Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways , 2001, European journal of immunology.

[84]  S. Shapiro,et al.  Macrophage elastase prevents Gemella morbillorum infection and improves outcome following murine bone marrow transplantation. , 1999, Chest.

[85]  G. Koh,et al.  Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. , 2000, Biochemical and biophysical research communications.

[86]  T. Poll,et al.  Animal and human models for sepsis , 2002, Annals of medicine.

[87]  J. Marshall,et al.  PRECLINICAL MODELS OF SHOCK AND SEPSIS: WHAT CAN THEY TELL US? , 2005, Shock.

[88]  Christine E. Becker,et al.  Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs , 2007, Seminars in Immunopathology.

[89]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[90]  H. Birkedal‐Hansen,et al.  MT1‐MMP: A tethered collagenase , 2004, Journal of cellular physiology.

[91]  J. Wrana,et al.  Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. , 1991, The Journal of biological chemistry.

[92]  E. Deitch ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED , 1998, Shock.

[93]  V. Pettilä,et al.  COLLAGENASE 2/MATRIX METALLOPROTEINASE 8 IN CRITICALLY ILL PATIENTS WITH SECONDARY PERITONITIS , 2007, Shock.

[94]  S. Husson,et al.  Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. , 2003, Biochemical and biophysical research communications.

[95]  Younghee Lee,et al.  NF-kappaB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264.7. , 2007, Journal of biochemistry and molecular biology.

[96]  M. Milla,et al.  The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. , 2002, Biochemistry.

[97]  L. Moldawer,et al.  Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[98]  K. Bodger,et al.  The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori. , 2006, Gastroenterology.

[99]  J. Platt,et al.  Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 41 , 2002, The Journal of Immunology.

[100]  Anne M Manicone,et al.  Matrix metalloproteinases as modulators of inflammation. , 2008, Seminars in cell & developmental biology.

[101]  K. Triantafilou,et al.  The dynamics of LPS recognition: complex orchestration of multiple receptors , 2005 .

[102]  J. Gordon,et al.  Bacterial Exposure Induces and Activates Matrilysin in Mucosal Epithelial Cells , 2000, The Journal of cell biology.

[103]  J. Platt,et al.  Conditional signaling by Toll‐like receptor 4 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  G. Rosenberg,et al.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[105]  K. Kirkwood,et al.  Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase , 2007, Journal of endotoxin research.

[106]  H. Matsuda,et al.  Mast cell MMP-9 production enhanced by bacterial lipopolysaccharide. , 2001, The Journal of veterinary medical science.

[107]  P. Libby,et al.  Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.

[108]  Jialiang Hu,et al.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases , 2007, Nature Reviews Drug Discovery.

[109]  J. Cavaillon,et al.  Cytokine Cascade in Sepsis , 2003, Scandinavian journal of infectious diseases.

[110]  G. Rosenberg,et al.  Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. , 2002, Brain research.

[111]  Stephen J. Weiss,et al.  Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.

[112]  Mark R. Wilson,et al.  Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity. , 2008, Biochemistry.

[113]  C. Brinckerhoff,et al.  Post‐Transcriptional regulationa of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts , 1992 .

[114]  V. Lagente,et al.  Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide. , 1999, Pulmonary pharmacology & therapeutics.

[115]  C. Overall,et al.  Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. , 2008, The American journal of pathology.

[116]  M. Lalu,et al.  Matrix metalloproteinases contribute to endotoxin and interleukin‐1β induced vascular dysfunction , 2006, British journal of pharmacology.

[117]  S. Tanase,et al.  Activation of Human Matrix Metalloproteinases by Various Bacterial Proteinases* , 1997, The Journal of Biological Chemistry.

[118]  M. Madigan,et al.  Brock Biology of Microorganisms , 1996 .

[119]  P. Bollaert Corticosteroids for septic shock. , 2008, The New England journal of medicine.

[120]  Rather Lj Disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by Galen to the four cardinal signs of Celsus. , 1971 .

[121]  M. Kaplan,et al.  The Gram Stain and Differential Staining , 1933, Journal of bacteriology.

[122]  K. Cohoon,et al.  Expression of Matrix Metalloproteinases Subsequent to Urogenital Chlamydia muridarum Infection of Mice , 2005, Infection and Immunity.

[123]  J. Shim,et al.  Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[124]  T. Ahrens,et al.  Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4 , 2002, The Journal of experimental medicine.

[125]  A. Sparreboom,et al.  Chemically modified tetracyclines as inhibitors of matrix metalloproteinases. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[126]  S. Maitra,et al.  Inhibition of Matrix Metalloproteinases by Chemically Modified Tetracyclines in Sepsis , 2003, Shock.

[127]  S. Hultgren,et al.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998, Science.

[128]  L. Moldawer,et al.  A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. , 1997, Shock.

[129]  K. Pfeffer,et al.  CECAL LIGATION AND PUNCTURE VERSUS COLON ASCENDENS STENT PERITONITIS: TWO DISTINCT ANIMAL MODELS FOR POLYMICROBIAL SEPSIS , 2004, Shock.

[130]  S. Landas,et al.  Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. , 2003, The Journal of surgical research.

[131]  M. Bianchi DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[132]  R. Andriantsitohaina,et al.  Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice. , 2007, The American journal of pathology.

[133]  B. Beutler,et al.  Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.

[134]  C. López-Otín,et al.  Membrane-Bound Matrix Metalloproteinase-8 on Activated Polymorphonuclear Cells Is a Potent, Tissue Inhibitor of Metalloproteinase-Resistant Collagenase and Serpinase1 , 2004, The Journal of Immunology.

[135]  H. Nguyen,et al.  Sepsis in the 21st century: recent definitions and therapeutic advances. , 2007, American Journal of Emergency Medicine.

[136]  D. Berg,et al.  Cag Pathogenicity Island-independent Up-regulation of Matrix Metalloproteinases-9 and -2 Secretion and Expression in Mice by Helicobacter pylori Infection* , 2006, Journal of Biological Chemistry.

[137]  C. Jackson,et al.  The dual personalities of matrix metalloproteinases in inflammation. , 2007, Frontiers in bioscience : a journal and virtual library.

[138]  L. He,et al.  Mesenchymal stem cell‐based angiopoietin‐1 gene therapy for acute lung injury induced by lipopolysaccharide in mice , 2007, The Journal of pathology.

[139]  T. Nakamura,et al.  Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment. , 1998, The American journal of the medical sciences.

[140]  D. Kwiatkowski,et al.  A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection , 2006, BMC Medical Genetics.

[141]  W. Parks,et al.  Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. , 1995, Journal of immunology.

[142]  L. Shapira,et al.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion , 1996, Infection and immunity.

[143]  V. Perry,et al.  Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.

[144]  X. Puente,et al.  LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity , 2007, PloS one.

[145]  Gerald Maurer,et al.  Catecholamines potentiate LPS‐induced expression of MMP‐1 and MMP‐9 in human monocytes and in the human monocytic cell line U937: possible implications for peri‐ operative plaque instability , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[146]  Carsten J. Kirschning,et al.  HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway* , 2002, The Journal of Biological Chemistry.

[147]  S. Opal The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. , 2007, International journal of medical microbiology : IJMM.

[148]  J. Varani,et al.  Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. , 2004, Experimental and molecular pathology.

[149]  G. Opdenakker,et al.  Gelatinase B deficiency protects against endotoxin shock , 2002, European journal of immunology.

[150]  T. Pruett Matrix Metalloproteinase-9 Deficiency Impairs Host Defense against Abdominal Sepsis , 2007 .

[151]  Charles J Malemud,et al.  Matrix metalloproteinases (MMPs) in health and disease: an overview. , 2006, Frontiers in bioscience : a journal and virtual library.

[152]  W. Hancock,et al.  Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 41 , 2001, The Journal of Immunology.

[153]  T. Betsuyaku,et al.  Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. , 1999, American journal of respiratory cell and molecular biology.

[154]  A. Stalder,et al.  Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice. , 2000, The American journal of pathology.

[155]  A. Mantovani,et al.  Toll-like receptor family and signalling pathway. , 2000, Biochemical Society transactions.

[156]  B. Cauwe,et al.  The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases , 2007, Critical reviews in biochemistry and molecular biology.

[157]  A. Sollevi,et al.  Differential release of matrix metalloproteinase‐9 and nitric oxide following infusion of endotoxin to human volunteers , 2003, Acta anaesthesiologica Scandinavica.

[158]  M. Lucia,et al.  Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. , 2004, American journal of physiology. Renal physiology.

[159]  W. Parks,et al.  Regulation of Matrilysin Expression in Airway Epithelial Cells by Pseudomonas aeruginosa Flagellin* , 2001, The Journal of Biological Chemistry.

[160]  S. Mobashery,et al.  Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood–brain barrier opening in rodents: Differences in response based on strains and solvents , 2007, Brain Research.

[161]  J. Shukla,et al.  Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock. , 2007, The Journal of surgical research.

[162]  C. Libert,et al.  Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation , 2007, Journal of leukocyte biology.

[163]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[164]  P. Gottschall,et al.  Increased production of gelatinase B (matrix metalloproteinase‐9) and interleukin‐6 by activated rat microglia in culture , 1995, Journal of neuroscience research.